Wednesday, February 10, 2010, 2:02PM AEST - The Australian Stockmarket closes in 2 hours and 3 minutes.
To create a watchlist or portfolio of shares, Register

Alexza Pharmaceuticals Inc. (ALXA)

7:59AM AEST: 2.6705 USD  Up 0.0205 (0.77%)  
 MORE ON ALXA 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Alexza Pharmaceuticals, Inc. (NGM:ALXA) Delayed quote dataEdit
Last Trade:2.6705 USD
Trade Time: 7:59AM AEST
Change:Up 0.0205 (0.77%)
Prev Close:2.65
Open:2.63
Bid:1.71 x 100
Ask:N/A
1y Target Est:6.40
Day's Range:2.59 - 2.7481
52wk Range:1.40 - 3.25
Volume:25,104
Avg Vol (3m):105,214
Market Cap:137.84M
P/E (ttm):N/A
EPS (ttm):-2.909
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add ALXA to Portfolio   Download Data

 HEADLINES 
Coverage initiated on Alexza Pharma by WBB Securities
Briefing.com (Fri, Jan 29)
Alexza Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
PR Newswire (Fri, Jan 29)
Alexza Takes Big Step Forward
Zacks.com (Fri, Dec 18)
Alexza Pharmaceuticals Inc. Announces Submission of AZ-004 NDA Call scheduled for 8:30 am ET today
CCBN (Wed, Dec 16)
JA Solar, Array BioPharma: Early Volume Plays
at TheStreet.com (Wed, Dec 16)
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
EDGAR Online (Tue, Dec 15)
Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
PR Newswire (Tue, Dec 15)
Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
PR Newswire (Fri, Nov 20)
ALEXZA PHARMACEUTICALS INC. Financials
EDGAR Online Financials (Sun, Nov 15)
Alexza Pharmaceuticals Inc. Earnings Call scheduled for 5:00 pm ET today
CCBN (Tue, Nov 10)
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Tue, Nov 10)
More Headlines for ALXA...

 ANALYST 
EPS Est (next year) (Dec-09) :-2.48
EPS Est (in 2 years) (Dec-10) :-0.82
Avg Rec (current)*:1.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Alexza Pharmaceuticals, Inc., a specialty pharmaceutical development stage company, focuses on the research, development, and commercialization of products for the acute treatment of central nervous system conditions.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices